The Pharmaceutical Rivalry Behind the Weight-Loss Drug Boom

The Pharmaceutical Rivalry Behind the Weight-Loss Drug Boom

0 Anmeldelser
0
Episode
328 of 877
Længde
15M
Sprog
Engelsk
Format
Kategori
Fakta

The multi-billion dollar weight-loss drug market has ballooned in the past few years. And the two pharmaceutical companies currently duking it out for market dominance, Novo Nordisk and Eli Lilly, have a century-long rivalry. Bloomberg News health reporter Madison Muller breaks down how Eli Lilly developed Zepbound, a new drug that can help patients cut more than 20% of their body weight — and why some investors and analysts think it will turn Eli Lilly into the first ever trillion-dollar drug company.

(Corrects characterization of the current size of the weight-loss drug market)

See omnystudio.com/listener for privacy information.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for The Pharmaceutical Rivalry Behind the Weight-Loss Drug Boom

Other podcasts you might like ...